Health ❯ Healthcare ❯ Medications

Weight Management

GLP-1 Drugs Mounjaro GLP-1 Receptor Agonists GLP-1 Medications Wegovy GLP-1 Agonists GLP-1 Treatments Obesity Treatments GLP-1 Therapy Tirzepatide Diabetes Prescription Drugs Obesity Treatment Tirzepatid Compounded Drugs Obesity Semaglutide Weight-loss Injections GLP-1s Zepbound KwikPen GLP-1 Therapies Eli Lilly Wegovy Tablets Weight Loss Treatments

10 ARTICLES

3w ago

FDA Approves Mounjaro to Lower Heart‑Attack and Stroke Risk in High‑Risk Type 2 Diabetes

The agency cleared the label on Aug. 28, 2026 after Lilly’s head‑to‑head SURPASS‑CVOT showed a modest cardiovascular advantage over Trulicity, a result that broadens Mounjaro’s clinical and commercial role.

13 ARTICLES

last mo.

UK Regulator Approves Eli Lilly’s Foundayo Tablet for Weight Loss and Type 2 Diabetes

5 ARTICLES

3mo ago

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

7 ARTICLES

4mo ago

Ashley Graham Calls GLP-1 Weight-Loss Craze a 'Smack in the Face' to Body Positivity

3 ARTICLES

4mo ago

Study Links GLP-1 Weight-Loss Drugs to Hair Shedding With Rapid Weight Loss

5 ARTICLES

6mo ago

Most Weight Lost on GLP-1 Drugs Returns After Stopping, New Analysis Finds

8 ARTICLES

7mo ago

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

8 ARTICLES

last yr.

Andy Cohen Says He Micro-Dosed a GLP-1 This Summer, Losing 25 Pounds